Please login to the form below
BlueRock Therapeutics
This page shows the latest BlueRock Therapeutics news and features for those working in and with pharma, biotech and healthcare.
Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
In 2019, Bayer bought out its private equity partner Versant Ventures and founders in BlueRock Therapeutics for $240m. ... In 2019, Bayer bought out its private equity partner Versant Ventures and founders in BlueRock Therapeutics for $240m, three years
Latest news
-
Bayer strengthens cell and gene therapy focus with new platform
The new cell and gene therapy platform will house both AskBio and another of Bayer’s recently acquired firms, BlueRock Therapeutics, under one roof. ... The German pharma company also bought out its private equity partner Versant Venture and founders
-
Bayer pays an initial $2bn for gene therapy firm AskBio
Samulski also created two AskBio subsidiaries, Bamboo Therapeutics and Chatham Therapeutics, which focused on Duchenne muscular dystrophy and haemophilia respectively. ... Bayer said that the AskBio acquisition complements its previous buy-out deal for
-
Bayer takes control of BlueRock stem cell joint venture
Deal values BlueRock at $1bn. Bayer is buying out private equity partner Versant Ventures and founders in its cell therapy joint venture BlueRock Therapeutics for $240m, three years after setting up ... The venture unit followed that a few weeks later
-
Bayer helps bankroll new stem cell company BlueRock
BlueRock Therapeutics comes into being with one of the largest debut financings ever granted to a biotech company, and is the second start-up to be backed by Bayer's investment ... BlueRock will have research and development operations in Toronto, New
More from news
Approximately 3 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
- MHRA to introduce new UK clinical trials framework
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- 2023 PM Society Awards – winners announced
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- Amgen gets block on sales of Repatha rival in Germany
- Congress is in session – how companies are boosting their impact and engagement
- The state of pharma customer experience
PMHub
IPG Health Medical Communications
We are the world's most celebrated and awarded Medical Communications agencies. We are 800 experts obsessed with combining science, creativity...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
